EGCG suppresses recepteur d’origine nantais (RON) expression in gastric cancer cells by inhibiting Egr-1 (-) [15] and blocked MMP-9 expression induced by nicotine in endothelial cells [48]. Here, MMP9 is linked to gastric cancer.